{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:49:30Z","timestamp":1767142170870,"version":"build-2238731810"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12185-019-02810-y","type":"journal-article","created":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T10:02:46Z","timestamp":1577872966000},"page":"724-732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression"],"prefix":"10.1007","volume":"111","author":[{"given":"Naoki","family":"Tamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirona","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"issue":"10","key":"2810_CR1","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1634\/theoncologist.11-10-1100","volume":"11","author":"SM Cohen","year":"2006","unstructured":"Cohen SM, Petryk M, Varma M, Kozuch PS, Ames ED, Grossbard ML. Non-Hodgkin\u2019s lymphoma of mucosa-associated lymphoid tissue. Oncologist. 2006;11(10):1100\u201317.","journal-title":"Oncologist"},{"key":"2810_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","volume":"24","author":"C Thieblemont","year":"2014","unstructured":"Thieblemont C, Bertoni F, Copie-Bergman C, Ferreri AJ, Ponzoni M. Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type. Semin Cancer Biol. 2014;24:33\u201342.","journal-title":"Semin Cancer Biol"},{"key":"2810_CR3","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1200\/JCO.2001.19.6.1600","volume":"19","author":"C Thiede","year":"2001","unstructured":"Thiede C, W\u00fcndisch T, Alpen B, Neubauer B, Morgner A, Schmitz M, et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol. 2001;19:1600\u20139.","journal-title":"J Clin Oncol"},{"key":"2810_CR4","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T W\u00fcndisch","year":"2005","unstructured":"W\u00fcndisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005;23:8018\u201324.","journal-title":"J Clin Oncol"},{"key":"2810_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4321\/S1130-01082007000700006","volume":"99","author":"LM Asenjo","year":"2007","unstructured":"Asenjo LM, Gisbert JP. Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review. Rev Esp Enferm Dig. 2007;99:398\u2013404.","journal-title":"Rev Esp Enferm Dig"},{"key":"2810_CR6","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1002\/cncr.22326","volume":"107","author":"S Nakamura","year":"2006","unstructured":"Nakamura S, Matsumoto T, Ye H, Nakamura S, Suekane H, Matsumoto H, et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer. 2006;107:2770\u20138.","journal-title":"Cancer"},{"key":"2810_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/asheducation-2005.1.307","volume":"2005","author":"C Thieblemont","year":"2005","unstructured":"Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematol Am Soc Hematol Educ Prog. 2005;2005:307\u201313.","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"2810_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12185-019-02719-6","volume":"110","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-2. Marginal zone lymphoma (MALT lymphoma\/extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue and splenic marginal zone lymphoma). Int J Hematol. 2019;110:393\u2013405.","journal-title":"Int J Hematol"},{"key":"2810_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1182\/blood.V99.1.3","volume":"99","author":"P Starostik","year":"2002","unstructured":"Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood. 2002;99:3\u20139.","journal-title":"Blood"},{"key":"2810_CR10","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1182\/blood-2002-10-3167","volume":"101","author":"H Ye","year":"2003","unstructured":"Ye H, Liu H, Raderer M, Chott A, Ruskone-Fourmestraux A, Wotherspoon A, et al. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood. 2003;101:2547\u201350.","journal-title":"Blood"},{"key":"2810_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nature06159","volume":"449","author":"C Cobaleda","year":"2007","unstructured":"Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature. 2007;449:473\u20137.","journal-title":"Nature"},{"key":"2810_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/bjo.2004.047092","volume":"89","author":"SE Coupland","year":"2005","unstructured":"Coupland SE, Hellmich M, Auw-Haedrich C, Lee WR, Anagnostopoulos I, Stein H. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases. Br J Ophthalmol. 2005;89:352\u20139.","journal-title":"Br J Ophthalmol"},{"key":"2810_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1309\/AJCP63OGXHXCSKSC","volume":"136","author":"TJ Molina","year":"2011","unstructured":"Molina TJ, Lin P, Swerdlow SH, Cook JR. Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol. 2011;136:211\u201325.","journal-title":"Am J Clin Pathol"},{"key":"2810_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","volume":"39","author":"KM Chisholm","year":"2015","unstructured":"Chisholm KM, Bangs CD, Bacchi CE, Molina-Kirsch H, Cherry A, Natkunam Y. Expression profiles of MYC protein and MYC gene rearrangement in lymphomas. Am J Surg Pathol. 2015;39:294\u2013303.","journal-title":"Am J Surg Pathol"},{"key":"2810_CR15","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00277-019-03671-5","volume":"98","author":"K Toyoda","year":"2019","unstructured":"Toyoda K, Maeshima AM, Nomoto J, Suzuki T, Yuda S, Yamauchi N, et al. Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results. Ann Hematol. 2019;98:1675\u201387.","journal-title":"Ann Hematol"},{"key":"2810_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2141.2003.04035.x","volume":"120","author":"SS Chuang","year":"2003","unstructured":"Chuang SS, Lee C, Hamoudi RA, Liu H, Lee PS, Ye H, et al. High frequency of t(11;18) in gastric mucosa-associated lymphoid tissue lymphomas in Taiwan, including one patient with high-grade transformation. Br J Haematol. 2003;120:97\u2013100.","journal-title":"Br J Haematol"},{"key":"2810_CR17","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1080\/10428190701606818","volume":"48","author":"X Ke","year":"2007","unstructured":"Ke X, Zhao L, Gao Z, Wang J, Dong F, Zhou X, et al. Higher rates of t(11;18) in Chinese patients with transformed type of MALT lymphoma suggest novel pathways for progression of the disease. Leuk Lymphoma. 2007;48:2157\u201366.","journal-title":"Leuk Lymphoma"},{"key":"2810_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000348550","volume":"130","author":"Y Suzuki","year":"2013","unstructured":"Suzuki Y, Yoshida T, Wang G, Aoki T, Katayama T, Miyamoto S, et al. Incidence and clinical significance of aberrant T-cell marker expression on diffuse large B-cell lymphoma cells. Acta Haematol. 2013;130:230\u20137.","journal-title":"Acta Haematol"},{"key":"2810_CR19","doi-asserted-by":"publisher","first-page":"33487","DOI":"10.18632\/oncotarget.16532","volume":"8","author":"N Tsuyama","year":"2017","unstructured":"Tsuyama N, Ennishi D, Yokoyama M, Baba S, Asaka R, Mishima Y, et al. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas. Oncotarget. 2017;8:33487\u2013500.","journal-title":"Oncotarget"},{"key":"2810_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1309\/AJCPNCOHS92ARWRQ","volume":"132","author":"G Carulli","year":"2009","unstructured":"Carulli G, Stacchini A, Marini A, Ciriello MM, Zucca A, Cannizzo E, et al. Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltration. Am J Clin Pathol. 2009;132:186\u201390.","journal-title":"Am J Clin Pathol"},{"key":"2810_CR21","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1200\/JCO.2008.21.5020","volume":"27","author":"C Laurent","year":"2009","unstructured":"Laurent C, Do C, Gascoyne RD, Lamant L, Ysebaert L, Laurent G, et al. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. J Clin Oncol. 2009;27:4211\u20136.","journal-title":"J Clin Oncol"},{"key":"2810_CR22","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/PAS.0b013e31825e63a9","volume":"36","author":"JL Oliveira","year":"2012","unstructured":"Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL. Clinicopathologic features of B-cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases. Am J Surg Pathol. 2012;36:1364\u201370.","journal-title":"Am J Surg Pathol"},{"key":"2810_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/modpathol.2017.177","volume":"31","author":"Z Pan","year":"2018","unstructured":"Pan Z, Chen M, Zhang Q, Wang E, Yin L, Xu Y, et al. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall. Mod Pathol. 2018;31:718\u201331.","journal-title":"Mod Pathol"},{"key":"2810_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/PAS.0000000000000753","volume":"41","author":"Z Pan","year":"2017","unstructured":"Pan Z, Hu S, Li M, Zhou Y, Kim YS, Reddy V, et al. ALK-positive large B-cell lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature. Am J Surg Pathol. 2017;41:25\u201338.","journal-title":"Am J Surg Pathol"},{"key":"2810_CR25","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2169\/internalmedicine.49.3164","volume":"49","author":"Y Suzuki","year":"2010","unstructured":"Suzuki Y, Yoshida T, Nakamura N, Kamata H, Kotani S, Ohsaka M, et al. CD3- and CD4-positive plasmablastic lymphoma: a literature review of Japanese plasmablastic lymphoma cases. Intern Med. 2010;49:1801\u20135.","journal-title":"Intern Med"}],"updated-by":[{"DOI":"10.1007\/s12185-020-02924-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T00:00:00Z","timestamp":1593302400000}}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02810-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02810-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02810-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T19:54:24Z","timestamp":1609358064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02810-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2810"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02810-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]},"assertion":[{"value":"20 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M. Nishikori receives honoraria from Eisai and funding from Eisai and Sumitomo Dainippon Pharmaceutical.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}